[1]CurrentPatentAssignee:SHENZHENCHIPSCREENBIOSCIENCESCOLTD-EP2860174,2017,B1Locationinpatent:Paragraph0040;0041
[2]CurrentPatentAssignee:SHANDONGCHUANCHENGPHARMACEUTICAL-CN105949114,2016,ALocationinpatent:Paragraph0009;0021;0022
[1]Hou,Lei;Zhang,Yunchang;Huang,Ying;Fang,Zhen;Sang,Guangze;Chen,Tianheng;Ma,Zhiqiang;Yang,Feng[MolecularPharmaceutics,2022,vol.19,#8,p.2807-2817]
[1]Hou,Lei;Zhang,Yunchang;Huang,Ying;Fang,Zhen;Sang,Guangze;Chen,Tianheng;Ma,Zhiqiang;Yang,Feng[MolecularPharmaceutics,2022,vol.19,#8,p.2807-2817]
[1]Hou,Lei;Zhang,Yunchang;Huang,Ying;Fang,Zhen;Sang,Guangze;Chen,Tianheng;Ma,Zhiqiang;Yang,Feng[MolecularPharmaceutics,2022,vol.19,#8,p.2807-2817]
[1]CurrentPatentAssignee:SOUTHCHINANORMALUNIVERSITY-CN115010725,2022,ALocationinpatent:Paragraph0054-0056;0059
Title: Chidamide, a novel histone deacetylase inhibitor, synergistically enhances gemcitabine cytotoxicity in pancreatic cancer cells.
Journal: Biochemical and biophysical research communications 20130426
Title: Increased PRAME-specific CTL killing of acute myeloid leukemia cells by either a novel histone deacetylase inhibitor chidamide alone or combined treatment with decitabine.
Journal: PloS one 20130101
Title: Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas.
Journal: Cancer chemotherapy and pharmacology 20120601
Title: Antitumor activity of Chidamide in hepatocellular carcinoma cell lines.
Journal: Molecular medicine reports 20120601
Title: CS055 (Chidamide/HBI-8000), a novel histone deacetylase inhibitor, induces G1 arrest, ROS-dependent apoptosis and differentiation in human leukaemia cells.
Journal: The Biochemical journal 20120501
Title: Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity.
Journal: Cancer chemotherapy and pharmacology 20120401
Title: Application of p21 and klf2 reporter gene assays to identify selective histone deacetylase inhibitors for cancer therapy.
Journal: Bioorganic & medicinal chemistry letters 20110101
Title: A novel histone deacetylase inhibitor Chidamide induces apoptosis of human colon cancer cells.
Journal: Biochemical and biophysical research communications 20100205